Cardinal Health 105, Inc Ketorolac Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Ketorolac from India and how much does Cardinal Health 105, Inc import?

India exports Ketorolac to 638 buyers globally worth $36.6M. Cardinal Health 105, Inc imports $350.0K (0.3% market share) with 7 shipments from UNITED STATES.

Q: What is the average order value for Cardinal Health 105, Inc's Ketorolac imports?

Cardinal Health 105, Inc's average Ketorolac order value is $50.0K per consignment, based on 7 shipments totaling $350.0K.

Q: Who supplies Ketorolac to Cardinal Health 105, Inc?

Top Indian Ketorolac suppliers: CAPLIN STERILES LIMITED ($11.5M), GLAND PHARMA LIMITED ($10.6M), GLAND PHARMA LTD ($9.7M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($4.8M), ALEMBIC PHARMACEUTICALS LIMITED ($3.5M).

Q: How does Cardinal Health 105, Inc compare to other Ketorolac importers?

Cardinal Health 105, Inc ranks #14 among 638 Ketorolac importers from India with 0.3% market share and 7 shipments.

Q: Who are the top Ketorolac importers from India?

Top Ketorolac importers: EVERSANA LIFE SCIENCE SERVICES ($12.4M), BAXTER HEALTHCARE CORPORATION ($6.0M), AO RANBAXY ($2.8M), NORTHSTAR DISTRIBUTION CENTER ($1.9M), JUNO PHARMACEUTICALS CORP ($1.7M).

Suresh Sormare

Ketorolac

India Pharmaceutical Trade Intelligence

$115.9M351 Suppliers124 CountriesHS 30049067

ExportsIndia → UNITED STATES63.1%India → RUSSIA23.4%

ImportsUNITED STATES → India$722.1K UNITED KINGDOM → India$13.4K

#1 Supplier: GLAND PHARMA #1 Buyer: EVERSANA LIFE

Cardinal Health 105, Inc — Ketorolac Importer #14 | $350.0K Trade Value | TransData Nexus | TransData Nexus

Cardinal Health 105, Inc — Ketorolac Importer Profile

Pharmaceutical Importer · #14 buyer for Ketorolac · $350.0K import value · 7 shipments · UNITED STATES · DGFT Verified

Cardinal Health 105, Inc is the #14 importer of Ketorolac from India with $350.0K in import value and 7 verified shipments. Cardinal Health 105, Inc holds a 0.3% market share in Ketorolac imports based in UNITED STATES. Overall, Cardinal Health 105, Inc imports 2 pharmaceutical products worth $600.0K across 2 therapeutic categories.

Cardinal Health 105, Inc — Ketorolac Import Profile: Suppliers, Formulations & Sources

Cardinal Health 105, Inc — Ketorolac import analysis from Indian Customs (DGFT) data.

Who Supplies Ketorolac to Cardinal Health 105, Inc?

Supplier	Value	Shipments	% Share
CAPLIN STERILES LIMITED	$11.5M	230	1
GLAND PHARMA LIMITED	$10.6M	212	5
GLAND PHARMA LTD	$9.7M	193	5
SUN PHARMACEUTICAL INDUSTRIES LIMITED	$4.8M	95

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ketorolac shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: Cardinal Health 105, Inc matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as Cardinal Health 105, Inc's capped import value divided by total capped export value for Ketorolac across all Indian exporters.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 124+ countries, 638+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ketorolac

Ketorolac

Cardinal Health 105, Inc — Ketorolac Importer Profile

Cardinal Health 105, Inc — Ketorolac Import Profile: Suppliers, Formulations & Sources

Who Supplies Ketorolac to Cardinal Health 105, Inc?

Regulatory Requirements: Importing Ketorolac into United States

Regulatory Authority

Approval Process for Generic Ketorolac

GMP Requirements

Import Licence & Documentation

Labeling & Packaging

Who Are the Top Buyers of Ketorolac from India and How Much Does Cardinal Health 105, Inc Import?

What Is the Average Order Value for Cardinal Health 105, Inc's Ketorolac Imports?

Who Supplies Ketorolac to Cardinal Health 105, Inc?

How Does Cardinal Health 105, Inc Compare to Other Ketorolac Importers?

About Cardinal Health 105, Inc

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ketorolac Import Data for Cardinal Health 105, Inc

Cardinal Health 105, Inc × Ketorolac

Company Overview

Top Products by Cardinal Health 105, Inc

Related Analysis

Need Detailed Import Data?

Data Source